| 2024-06-07 | Sale | Protagonist Therapeutics, Inc. PTGX | director | 8,000 0.0137% | $35.00 | $280,000 | -6.35% | |
| 2024-03-01 | Sale | Protagonist Therapeutics, Inc. PTGX | director | 12,975 0.0219% | $31.34 | $406,637 | -10.36% | |
| 2024-01-11 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | director | 3,934 0.0037% | $38.07 | $149,759 | -29.51% | |
| 2023-01-09 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | director | 3,200 0.003% | $30.00 | $96,000 | +0.59% | |
| 2022-01-03 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | director | 4,500 0.0039% | $64.72 | $291,244 | -43.25% | |
| 2021-01-04 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | director | 3,750 0.0037% | $76.08 | $285,300 | -7.79% | |
| 2020-12-10 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | director | 3,000 0.0028% | $71.26 | $213,780 | -5.75% | |
| 2020-05-11 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | director | 26,000 0.0257% | $36.54 | $950,040 | +70.58% | |
| 2019-01-11 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | director | 17,000 0.0179% | $14.77 | $251,090 | +86.95% |